150
Participants
Start Date
September 4, 2017
Primary Completion Date
July 6, 2019
Study Completion Date
July 6, 2019
Zirconium Cyclosilicate
Correction Phase Dosing: Sodium Zirconium Cyclosilicate 10 g three times daily (TID) from 24 to 72 Extended Dosing: Sodium Zirconium Cyclosilicate 5 g once daily (QD). Sodium Zirconium Cyclosilicate dose increased or decreased in increments/decrements of 5 g QD up to a maximum of 15 g QD or a minimum of 5 g every other day (QOD) (or 2.5 g QD) based on i-STAT potassium measurements up to 12 months.
Research Site, Akashi-shi
Research Site, Amagasaki-shi
Research Site, Chiba
Research Site, Chiba
Research Site, Chiyoda-ku
Research Site, Chūōku
Research Site, Funabashi-shi
Research Site, Hanyu-shi
Research Site, Higashiibaraki-gun
Research Site, Hitachi-Naka
Research Site, Ina-shi
Research Site, Kagoshima
Research Site, Kahoku-gun
Research Site, Kamakura-shi
Research Site, Kasuga-shi
Research Site, Kasugai-shi
Research Site, Kasugai-shi
Research Site, Kawachinagano-shi
Research Site, Kawasaki-shi
Research Site, Kitakyushu-shi
Research Site, Kochi
Research Site, Koga-shi
Research Site, Koga-shi
Research Site, Kumamoto
Research Site, Matsudo-shi
Research Site, Matsuyama
Research Site, Minokamo-shi
Research Site, Mito
Research Site, Nagoya
Research Site, Naka
Research Site, Omura-shi
Research Site, Onomichi-shi
Research Site, Osaka
Research Site, Osaka
Research Site, Osaka
Research Site, Shimajiri-gun
Research Site, Shizuoka
Research Site, Toride-shi
Research Site, Toshima-ku
Research Site, Toyohashi
Research Site, Yakushi
Research Site, Yotsukaido-shi
Lead Sponsor
AstraZeneca
INDUSTRY